Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPC1 | O15118 | 13/20 | 0.60 |
| ▸ | RAB9A | P51151 | 12/20 | 0.60 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.60 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.60 |
| ▸ | MAPT | P10636 | 3/20 | 0.60 |
| ▸ | LMNA | P02545 | 3/20 | 0.60 |
| ▸ | HTT | P42858 | 2/20 | 0.60 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.60 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.60 |
| ▸ | AGTR1 | P30556 | 7/20 | 0.56 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.56 |
| ▸ | POLB | P06746 | 2/20 | 0.56 |
| ▸ | GAA | P10253 | 6/20 | 0.54 |
| ▸ | OPRK1 | P41145 | 6/20 | 0.51 |
| ▸ | MEN1 | O00255 | 3/20 | 0.51 |
| ▸ | PKM | P14618 | 2/20 | 0.51 |
| ▸ | MITF | O75030 | 1/20 | 0.49 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7678715 | 1.00 | NPC1 (0.60) | NPC1RAB9ASMN1; SMN2L3MBTL1MAPT | |
| SCHEMBL7558890 | 0.82 | RAB9A (0.40) | NPC1RAB9ASMN1; SMN2L3MBTL1MAPT | |
| SCHEMBL7558896 | 0.82 | RAB9A (0.40) | NPC1RAB9ASMN1; SMN2L3MBTL1MAPT | |
| SCHEMBL7561090 | 0.79 | MAPT (0.50) | NPC1RAB9ASMN1; SMN2L3MBTL1MAPT | |
| SCHEMBL7529205 | 0.79 | NPC1 (0.50) | NPC1RAB9ASMN1; SMN2L3MBTL1MAPT | |
| SCHEMBL7558851 | 0.79 | NPC1 (0.50) | NPC1RAB9ASMN1; SMN2L3MBTL1MAPT | |
| SCHEMBL7561095 | 0.79 | MAPT (0.50) | NPC1RAB9ASMN1; SMN2L3MBTL1MAPT | |
| SCHEMBL7535844 | 0.78 | RAB9A (0.60) | NPC1RAB9ASMN1; SMN2L3MBTL1MAPT | |
| SCHEMBL7564275 | 0.78 | RAB9A (0.60) | NPC1RAB9ASMN1; SMN2L3MBTL1MAPT | |
| SCHEMBL7561222 | 0.77 | MAPT (0.61) | NPC1RAB9ASMN1; SMN2L3MBTL1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20020091148-A1 | 3-substituted indole antiproliferative angiogenesis inhibitors | ABBOTT LABORATORIES | 2002-07-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020091148-A1 | 3-substituted indole antiproliferative angiogenesis inhibitors | MKI67, FLT4, IDO1 | NPC1 3749/4885RAB9A 3961/4885SMN1; SMN2 4745/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.